Hypertension
📧 Sign up to get email alerts when something new happens for Hypertension.
Sign up freeTop drugs studied for this disease
-
FDA approval · 2006-10-20FDA Approved: COREG CR — Original Application (Waylis Therapeutics LLC)
FDA approved COREG CR, an extended-release formulation of carvedilol phosphate, under an original NDA from Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2006-10-17Clinical Trial Update: Improving Medication Use in Patients With Hypertension [NA]
This document provides an update on a completed clinical trial aimed at improving medication use in patients with hypertension.
-
CLINICAL_TRIALS research · 2006-10-17Clinical Trial Update: Renal Artery Calcium and Hypertension
An update on a clinical trial examining the relationship between renal artery calcium and hypertension, sponsored by Hadassah Medical Organi…
-
CLINICAL_TRIALS research · 2006-10-13Clinical Trial Update: Anticipatory & Preventive Team Care (APTCare): At Risk Patients of Family Health Networks [Phase 2, Phase 3]
An update on the Phase 2 and Phase 3 trial Anticipatory & Preventive Team Care (APTCare) for at-risk patients within Family Health Networks,…
-
CLINICAL_TRIALS research · 2006-10-09Clinical Trial Update: Evaluation of a New Blood Pressure Measuring Device. [NA]
An update on a clinical trial evaluating a new blood pressure measuring device for hypertension; current status is unknown.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2006-10-04Clinical Trial Update: Prevalence of Chronic KIdney Disease in Hypertensive Patients
This clinical trial update reviews the prevalence of chronic kidney disease among patients with hypertension.
-
FDA approval · 2006-09-27FDA Approved: LISINOPRIL AND HYDROCHLOROTHIAZIDE — Original Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin's lisinopril and hydrochlorothiazide as a generic fixed-dose combination for the treatment of hypertension.
-
CLINICAL_TRIALS trial_result · 2006-09-19Clinical Trial Update: Mechanisms and Therapeutic Effects of the Relaxation Response in Elderly Hypertensive Patients [Phase 2]
Phase 2 clinical trial completed to evaluate the relaxation response as a mechanism and potential blood pressure-lowering effect in elderly …
-
FDA approval · 2006-09-18FDA Approved: FUROSEMIDE — Original Application (Ipca Laboratories Limited)
FDA approved the Original Application for furosemide from Ipca Laboratories Limited, enabling a generic version of the diuretic to be market…
-
FDA approval · 2006-09-13FDA Approved: ATENOLOL — Original Application (Rising Pharma Holdings, Inc.)
FDA approved Atenolol as a generic under ANDA077443 from Rising Pharma Holdings, Inc. for the treatment of hypertension, angina pectoris, an…
-
CLINICAL_TRIALS trial_result · 2006-09-11Clinical Trial Update: Integrating Family Medicine and Pharmacy to Advance Primary Care Therapeutics [Phase 4]
A Phase 4 clinical trial evaluating integration of family medicine and pharmacy to advance primary care therapeutics has completed.
-
FDA approval · 2006-08-29FDA Approved: HYZAAR — Supplemental Application (Organon LLC)
FDA approved a supplemental application for HYZAAR (losartan potassium and hydrochlorothiazide) submitted by Organon LLC.
-
FDA label_change · 2006-08-28FDA Approved: AMLODIPINE AND ATORVASTATIN — Supplemental Application (Prasco Laboratories)
FDA approved a supplemental application for the fixed-dose combination of amlodipine and atorvastatin from Prasco Laboratories, resulting in…
-
FDA approval · 2006-08-28FDA Approved: COREG — Supplemental Application (Waylis Therapeutics LLC)
The FDA approved a supplemental application for Coreg (carvedilol) submitted by Waylis Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Acupuncture and Hypertension [NA]
A completed clinical trial evaluating acupuncture for hypertension. Sponsored by the National Center for Complementary and Integrative Healt…
-
CLINICAL_TRIALS trial_result · 2006-08-18Clinical Trial Update: Use of Complementary and Alternative Medicine Among Older Mexican Americans
This ClinicalTrials.gov entry reports that the study on complementary and alternative medicine use among older Mexican Americans sponsored b…
-
FDA approval · 2006-08-17FDA Approved: CANDESARTAN CILEXETIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved ANI Pharmaceuticals' supplemental application for candesartan cilexetil and hydrochlorothiazide, authorizing a fixed-dose c…
-
FDA approval · 2006-08-17FDA Approved: ATACAND — Supplemental Application (ANI Pharmaceuticals, Inc.)
FDA approved a supplemental application for ATACAND (candesartan cilexetil) submitted by ANI Pharmaceuticals, Inc., to modify or expand the …
-
FDA approval · 2006-08-14FDA Approved: CAPTOPRIL AND HYDROCHLOROTHIAZIDE — Supplemental Application (Rising Pharma Holdings, Inc.)
FDA approved a supplemental application for CAPTOPRIL AND HYDROCHLOROTHIAZIDE from Rising Pharma Holdings, Inc., to support its ongoing use …
-
FDA approval · 2006-08-08FDA Approved: LISINOPRIL — Supplemental Application (Quallent Pharmaceuticals Health LLC)
FDA approved a supplemental application for lisinopril from Quallent Pharmaceuticals Health LLC.
-
CLINICAL_TRIALS research · 2006-08-07Clinical Trial Update: Study of Optimal Treatment Plan in Hypertensives With Anti-AT1-Receptor Autoantibody [Phase 4]
Phase 4 study evaluating the optimal treatment plan for hypertensive patients with anti-AT1 receptor autoantibodies. The current status is n…
-
CLINICAL_TRIALS trial_result · 2006-07-28Clinical Trial Update: A Long Term Study of SPP100 in Patients With Essential Hypertension (Trial is Not Recruiting in the US) [Phase 2]
A completed Phase 2 long-term trial evaluating SPP100 for essential hypertension; the study is not recruiting in the United States.
-
FDA approval · 2006-07-27FDA Approved: TOPROL XL — Supplemental Application (Melinta Therapeutics, LLC)
The FDA approved a supplemental application for TOPROL XL (metoprolol succinate) from Melinta Therapeutics, LLC. The approval updates the pr…
-
CLINICAL_TRIALS trial_result · 2006-07-26Clinical Trial Update: Safety and Effects of Ramipril Combined With Candesartan [Phase 4]
Phase 4 trial assessing the safety and effects of combining ramipril with candesartan in hypertension; study completed.
-
FDA approval · 2006-07-17FDA Approved: ATENOLOL — Supplemental Application (Zydus Lifesciences Limited)
The FDA approved a supplemental application for Atenolol filed by Zydus Lifesciences Limited (ANDA 076900).